Castle Biosciences Inc (CSTL): Capital Expenditures
$36.02M
Year ended 2025-12-31
$43.12M
Trailing 12 months to 2026-06-30
+85.6%
3-year compound annual growth
+50.0%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.02M | +27.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $28.33M | +108.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $13.62M | +141.9% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $5.63M | +61.7% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $3.48M | -26.7% | 2023-02-28, From 2021-01-01 |
| 2020-12-31 | $4.75M | +407.0% | 2022-02-28, From 2020-01-01 |
| 2019-12-31 | $937.0K | +238.3% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $277.0K | n/a | 2020-03-10, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $8.88M | +64.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $9.68M | -14.3% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $909.0K | -82.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $16.26M | +92.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $48.31M | +37.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | $259.0K | -92.0% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $4.50M | +181.0% |
Compare CSTL, FLGT, BLLN, VCYT side by side · Screen every company in Services-Medical Laboratories ↗